Cleared Traditional

K810239 - VENTED PRIMARY PIGGYBACK VENOSET DUAL

K810239 is an FDA 510(k) clearance for VENTED PRIMARY PIGGYBACK VENOSET DUAL, manufactured by Abbott Laboratories. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 121-day FDA review.

K810239 · Abbott Laboratories · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1981
Decision
121d
Days
Class 2
Risk

K810239 is an FDA 510(k) clearance for the VENTED PRIMARY PIGGYBACK VENOSET DUAL. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on May 29, 1981 after a review of 121 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K810239

510(k) Number K810239 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 28, 1981
Decision Date May 29, 1981
Days to Decision 121 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 129d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 532
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K810239.
IV SETS
K811107 · Critikon Company, LLC · Jun 1981
AUTO-SYRINGE MICRO VOLUME EXTENSION SET
K811463 · Baxter Healthcare Corp · Jun 1981
MODELS: 52-01-0, 52-01-1
K811110 · Y · Jun 1981
NITROGLYCERINE IV SET
K810317 · Abbott Laboratories · May 1981
HAEMONETICS 170 Y INFUSION SET
K810365 · Haemonetics Corp. · Mar 1981
PRIMARY SOLUTION ADMIN. SET-#86-01-0 260
K801871 · Y · Aug 1980